Drug: spironolactone Quarter: 2016Q3
Total Records: 467 Number of Pages: 24
| DRUGNAME | PT | EventCount |
|---|---|---|
| SPIRONOLACTONE TABLETS 100MG | Breast enlargement | 1 |
| SPIRONOLACTONE TABLETS 100MG | Breast pain | 1 |
| SPIRONOLACTONE TABLETS 100MG | Breast tenderness | 1 |
| SPIRONOLACTONE TABLETS 100MG | Chest pain | 1 |
| SPIRONOLACTONE TABLETS 100MG | Drug ineffective | 1 |
| SPIRONOLACTONE TABLETS 100MG | Drug ineffective for unapproved indication | 1 |
| SPIRONOLACTONE TABLETS 100MG | Intentional product use issue | 1 |
| SPIRONOLACTONE TABLETS 100MG | Localised oedema | 1 |
| SPIRONOLACTONE TABLETS 100MG | Nodule | 1 |
| SPIRONOLACTONE TABLETS 25MG | Aphthous ulcer | 1 |
| SPIRONOLACTONE TABLETS 25MG | Diarrhoea | 1 |
| SPIRONOLACTONE TABLETS 25MG | Glossodynia | 1 |
| SPIRONOLACTONE TABLETS 25MG | Hepatic enzyme increased | 1 |
| SPIRONOLACTONE TABLETS 25MG | Hypersensitivity | 1 |
| SPIRONOLACTONE TABLETS 25MG | Malaise | 1 |
| SPIRONOLACTONE TABLETS 25MG | Product physical issue | 1 |
| SPIRONOLACTONE TABLETS 25MG | Red blood cell sedimentation rate increased | 1 |
| SPIRONOLACTONE TABLETS 25MG | Tongue discomfort | 1 |
| SPIRONOLACTONE TABLETS 25MG | Tongue eruption | 1 |
| SPIRONOLACTONE TABLETS 25MG | Weight increased | 1 |
Total Records: 467 Number of Pages: 24